EODData

MEMBERSHIP REGISTER LOG IN

SHE, 300142: Walvax BioTech

09 Oct 2025
LAST:

11.71

CHANGE:
 0.10		OPEN:
11.66		HIGH:
11.76		ASK:
0.00		VOLUME:
21.76M
CHG(%):
0.86		PREV:
11.61		LOW:
11.54		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Oct 2511.6611.7611.5411.7121.76M
30 Sep 2511.5711.6911.5311.6119.18M
29 Sep 2511.4411.6011.2511.5321.95M
26 Sep 2511.6211.6211.4511.4518.31M
25 Sep 2511.7211.8511.6011.6319.62M
24 Sep 2511.6411.7411.5911.7319.57M
23 Sep 2511.8411.8411.4411.6730.29M
22 Sep 2511.9912.1511.7011.8924.07M

COMPANY PROFILE

Name:Walvax BioTech
About:Walvax Biotechnology Co., Ltd., researches, develops, produces, and markets vaccines in China. The company offers SARS-CoV-2 mRNA vaccine, an immunization to prevent COVID-19 to individuals 18 years of age and older; 13-valent pneumococcal polysaccharide conjugate vaccine, an invasive diseases caused by streptococcus pneumoniae for use in infants and children 6 weeks through 5 years of age; and recombinant human papillomavirus bivalent vaccine, for the prevention of cervical cancers and precancerous lesions caused by human; 23-valent pneumococcal polysaccharide vaccine, for individuals age 2 years of pneumococcal diseases; ACYW135 meningococcal polysaccharide vaccine, for the prevention of invasive meningococcal diseases; Group A and C meningococcal polysaccharide vaccine, for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium neisseria meningitidis; Group A and Group C meningococcal conjugate vaccine, for the prevention of invasive meningococcal diseases caused by Neisseria meningitidis serogroups A and C for children 3 months through 5 years of age. It also provides haemophilus influenzae type b conjugate vaccine, for the prevention of invasive infections for children 2 months through 5 years of age; diphtheria, tetanus, and acellular pertussis combined vaccine, for diphtheria and tetanus for infants and children 3 months through 6 years of age. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
Sector:Healthcare
Address:No. 395 Kexin Road, Kunming, China, 650101
Website:https://www.walvax.com
ISIN:CNE100000WN2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:166.75
DivYield:0.00
Div/Share:0.01
Price to Book:2.23
Price to Sales:7.95
EBITDA:281.89M
Shares:1.599B
Market Cap:18.728B

TECHNICAL INDICATORS

MA5:11.59
MA10:11.73
MA20:12.05
MA50:12.60
MA100:11.70
MA200:11.65
STO9:34.67
STO14:19.55
RSI14:24.83
WPR14:-73.74
MTM14:-0.73
ROC14:-0.06
ATR:0.29
Week High:11.76
Week Low:11.54
Month High:12.78
Month Low:11.25
Year High:18.98
Year Low:9.70
Volatility:21.86